SAM37 Antibody

What is SAM37 and why is it important in mitochondrial research?

SAM37 (also known as Sam37 or Sorting and Assembly Machinery subunit 37) is a peripheral membrane protein component of the mitochondrial SAM complex. It plays critical roles in:

• Coupling the Translocase of the Outer Membrane (TOM) and SAM complexes to form a supercomplex

• Facilitating transfer of β-barrel precursors between TOM and SAM complexes

• Maintaining mitochondrial DNA stability in fungi like Candida albicans

• Contributing to cell wall integrity in pathogenic fungi

Unlike core SAM complex proteins like Sam50 and Sam35 that are directly involved in β-barrel precursor recognition, Sam37 functions primarily as a coupling factor that enables efficient protein transfer between complexes and promotes assembly of mitochondrial proteins .

Interestingly, the function of Sam37 differs significantly between species. In Saccharomyces cerevisiae, Sam37 is not required for mitochondrial DNA stability, while in C. albicans, inactivation of SAM37 leads to substantial mitochondrial DNA loss .

What are the validated applications for SAM37 antibodies in research?

Based on available research data, SAM37 antibodies have been validated for several key applications:

When selecting a SAM37 antibody for your research, verify that it has been validated for your specific application according to at least one of the five validation pillars described in the literature .

How should I validate a commercial SAM37 antibody for my specific application?

To ensure reliable results, validate your SAM37 antibody using at least one of these five established validation strategies:

• Genetic strategy: Use CRISPR-Cas9 knockout or RNAi knockdown of SAM37 to confirm specificity. A significant reduction in signal should be observed in the knockdown/knockout samples compared to wild-type .

• Orthogonal strategy: Compare antibody-based detection with an antibody-independent method such as targeted mass spectrometry. Protein levels detected by both methods should show strong correlation .

• Independent antibody strategy: Use two antibodies targeting different epitopes of SAM37. Both should show similar staining patterns or signal intensities .

• Tagged protein expression: Express SAM37 with an epitope tag and compare detection of the native protein with detection of the tag .

• Immunocapture followed by mass spectrometry (IMS): Capture SAM37 using the antibody and analyze by mass spectrometry. SAM37 peptides should be among the most abundant detected .

For each application, specific validation criteria must be met:

The validation method should be selected based on your specific experimental context and available resources .

What experimental controls are essential when working with SAM37 antibodies?

When designing experiments with SAM37 antibodies, incorporate these essential controls:

• Negative controls:

  • Isotype control antibody for immunoprecipitation experiments

  • Secondary antibody only for immunostaining

  • Samples lacking SAM37 (knockout/knockdown if available)

  • Non-expressing tissues/cells for tissue-specific experiments

• Positive controls:

  • Tissues/cells known to express SAM37

  • Recombinant SAM37 protein (particularly useful for western blots)

  • Overexpression systems for SAM37

• Blocking controls:

  • Pre-incubation of antibody with immunizing peptide to confirm specificity

  • Competitive binding assays

• Loading and transfer controls:

  • Housekeeping proteins (e.g., GAPDH, β-actin) for western blots

  • Total protein staining for normalization

For experiments involving mitochondrial fractionation, include markers for different mitochondrial compartments (outer membrane, inner membrane, matrix) to confirm proper isolation and purity .

How can I troubleshoot common issues with SAM37 antibody experiments?

When facing challenges with SAM37 antibody experiments, consider these methodological solutions:

For weak or absent signal:

• Optimize antibody concentration through titration experiments

• Extend primary antibody incubation time (overnight at 4°C often improves results)

• For western blots, try different blocking agents (BSA vs. milk)

• For mitochondrial proteins, ensure proper sample preparation to expose epitopes

• Consider different detergents for membrane protein extraction (digitonin preserves protein complexes better than stronger detergents)

For high background:

• Increase washing steps and duration

• Reduce antibody concentration

• Try different blocking agents

• For immunofluorescence, include an autofluorescence quenching step

• For immunohistochemistry, optimize antigen retrieval methods

For non-specific bands:

• Use gradient gels for better separation

• Optimize lysis conditions to prevent protein degradation

• Include protease inhibitors in all buffers

• Consider using mitochondrial fractionation to enrich for target proteins

How can I design experiments to study the interaction between SAM37 and Tom22?

To investigate the SAM37-Tom22 interaction that facilitates formation of the TOM-SAM supercomplex, consider these advanced methodological approaches:

• Cross-linking studies:

  • Use bismaleimidoethane (BMOE) for cysteine-specific cross-linking

  • Create Tom22 cysteine mutants (particularly at positions around amino acid 66 in the cytosolic domain) to map interaction sites

  • Perform cross-linking in intact mitochondria followed by immunoprecipitation with anti-SAM37 antibodies

• Affinity purification of intact complexes:

  • Use digitonin for gentle lysis that preserves protein-protein interactions

  • Create strains expressing His-tagged Tom22 for affinity purification

  • Analyze copurified proteins by western blot using anti-SAM37 antibodies

  • Quantify the interaction efficiency by comparing protein ratios

• Fusion protein approaches:

  • Create fusion proteins between cytochrome b2 and the cytosolic domain of Tom22

  • Test interaction with SAM37 using in vitro binding assays

  • Map the interaction domains through truncation mutants

• FRET-based interaction studies:

  • Express fluorescently tagged versions of SAM37 and Tom22

  • Measure FRET efficiency as an indicator of protein proximity

  • Use acceptor photobleaching to confirm specific interactions

The experimental data suggests that SAM37 specifically interacts with the cytosolic receptor domain of Tom22, particularly with the second half of this domain (around amino acids 66-94) .

What approaches can I use to investigate SAM37's role in mitochondrial DNA stability in fungal species?

To study SAM37's unexpected role in mitochondrial DNA maintenance in fungi like C. albicans, implement these specialized methodologies:

• Quantitative assessment of mtDNA loss:

  • Use DAPI staining to visualize and quantify cells with mtDNA

  • Employ quantitative PCR to measure the ratio of nuclear (ACT1) versus mtDNA genes (COX1 and ATP6)

  • Analyze at least 200 cells per strain and perform in triplicate

• Functional assays for mitochondrial genome integrity:

  • Test growth on respiratory carbon sources (e.g., glycerol) to assess functional mitochondria

  • Use Mitotracker Red staining to examine mitochondrial morphology

  • Analyze mitochondrial membrane potential with potential-sensitive dyes

• Genetic complementation experiments:

  • Create SAM37 mutants with targeted mutations in specific domains

  • Express these in sam37ΔΔ backgrounds and quantify mtDNA rescue

  • Compare with known mtDNA stability factors like HMI1

• Investigation of SAM37's interaction with mtDNA maintenance machinery:

  • Analyze potential interactions with ERMES (ER-Mitochondria Encounter Structure)

  • Investigate connections with the MICOS (Mitochondrial Contact Site) complex

  • Perform co-immunoprecipitation studies followed by mass spectrometry

Analysis of C. albicans sam37ΔΔ mutants revealed that 76.6% ± 3.4% of cells were devoid of mtDNA, demonstrating SAM37's crucial role in mtDNA maintenance in this organism, a function not conserved in S. cerevisiae .

How can I design experiments to distinguish the different functional roles of SAM37?

SAM37 has multiple distinct functional roles that can be separated experimentally using these sophisticated approaches:

• Investigating TOM-SAM supercomplex formation:

  • Purify mitochondria and solubilize with digitonin

  • Perform blue native gel electrophoresis to identify intact complexes

  • Use antibodies against Tom and Sam components to identify supercomplexes

  • Compare wild-type and sam37Δ samples to assess supercomplex formation

• Examining precursor transfer function:

  • Import radiolabeled β-barrel precursors (e.g., Tom40, Porin) into isolated mitochondria

  • Use blue native electrophoresis to separate assembly intermediates

  • Look specifically for precursor association with the SAM complex

  • Use Tom40 G354A and Porin G276I variants that accumulate at the SAM complex

• Reconstitution experiments:

  • Purify sam37Δ mitochondria and attempt to restore function by importing:
    a) In vitro synthesized wild-type SAM37
    b) SAM37 mutants with specific domain alterations
    c) Control proteins (e.g., Tom5) that should not rescue the phenotype

• Distinguishing early vs. late SAM37 functions:

  • Track multiple assembly stages of β-barrel proteins using blue native electrophoresis

  • Compare the effects of SAM37 deletion on early (precursor binding to SAM) vs. late (mature complex formation) stages

  • Use pulse-chase experiments to separate temporal aspects of protein biogenesis

• Separating structural vs. functional roles:

  • Overexpress Sam35 in sam37Δ cells to stabilize the Sam35-Sam50 subcomplex

  • Test whether this rescues specific aspects of SAM37 function

  • Examine whether TOM-SAM coupling is restored (it is not, confirming SAM37's specific role)

These experiments reveal that SAM37 has dual roles: (1) coupling the TOM and SAM complexes through interaction with Tom22 and (2) stabilizing the SAM complex and facilitating later stages of precursor maturation .

What methods can I use to study the cell wall defects in SAM37-deficient fungal pathogens?

To investigate the link between mitochondrial SAM37 and cell wall integrity in fungi like C. albicans, employ these specialized methodologies:

• Cell wall composition analysis:

  • Isolate cell walls and fractionate into alkali-soluble and alkali-insoluble components

  • Quantify β-1,3-glucan, β-1,6-glucan, chitin, and mannan content

  • Compare wild-type, sam37ΔΔ, and reconstituted strains

• Cell wall stress response assays:

  • Test sensitivity to cell wall-targeting drugs (e.g., Calcofluor White, Congo Red)

  • Examine sensitivity to cell membrane-targeting antifungals

  • Monitor growth under osmotic stress conditions

• PKC pathway activation analysis:

  • Monitor phosphorylation of Mkc1 (MAP kinase) under basal and stress conditions

  • Compare activation in response to specific cell wall stressors

  • Contrast with S. cerevisiae pgs1Δ cells which show different phenotypes

• Proteomics approaches for GPI-anchored proteins:

  • Develop quantitative proteomics using SILAC (stable isotope labeling by amino acids in cell culture)

  • Focus on changes in GPI-anchored cell wall proteins

  • Examine phosphatidylethanolamine (PE) biosynthesis, which requires SAM37 and affects GPI anchor maturation

• In vivo virulence and filamentation studies:

  • Use mouse models of systemic candidiasis to assess virulence

  • Perform histopathology analysis of infected tissues

  • Quantify infection foci and filamentation in host tissues

Research has shown that C. albicans sam37ΔΔ mutants display altered cell wall structure and hypersensitivity to cell wall-targeting drugs, without showing significant changes in glucan levels, suggesting complex relationships between mitochondrial function and cell wall integrity .

What are the most effective approaches for antibody validation in SAM37 research when knockout models are unavailable?

When knockout models for SAM37 are unavailable or challenging to generate, consider these alternative validation approaches:

• RNA interference approaches:

  • Use siRNA or shRNA to knockdown SAM37 expression

  • Verify knockdown efficiency by qRT-PCR

  • Compare antibody signal between knockdown and control samples

  • Quantify the degree of signal reduction in relation to knockdown efficiency

• Orthogonal validation with mass spectrometry:

  • Use targeted proteomics with labeled internal standards to quantify SAM37 across multiple samples

  • Correlate antibody-based detection with MS quantification

  • Analyze samples with variable SAM37 expression levels for robust statistical comparison

  • A strong correlation indicates antibody specificity

• Independent antibody validation:

  • Use two antibodies recognizing different epitopes of SAM37

  • Compare staining patterns and signal intensities

  • Quantify correlation coefficients between signals

  • Agreement between different antibodies supports specificity

• Peptide competition assays:

  • Pre-incubate antibody with the immunizing peptide

  • Compare results with and without peptide competition

  • A specific antibody should show significantly reduced signal when blocked with the specific peptide

• Immunocapture-mass spectrometry (IC-MS):

  • Perform immunoprecipitation with the SAM37 antibody

  • Analyze captured proteins by mass spectrometry

  • The antibody is considered specific if SAM37 peptides are among the top three most abundant peptides identified